Search results for "1R"

showing 10 items of 102 documents

CCDC 297366: Experimental Crystal Structure Determination

2006

Related Article: E.Schweizer, A.Hoffmann-Roder, J.A.Olsen, P.Seiler, U.Obst-Sander, B.Wagner, M.Kansy, D.W.Banner, F.Diederich|2006|Org.Biomol.Chem.|4|2364|doi:10.1039/b602585d

Space GroupCrystallographyCrystal Systemrac-(1S3aS4R8aS8bR)/(1R3aR4S8aR8bS)-4-(4-Bromophenyl)-2-((4-fluorophenyl)methyl)-1-hydroxyoctahydrodipyrrolo(12-a:3'4'-c)pyrrol-3(2H)-oneCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 704876: Experimental Crystal Structure Determination

2009

Related Article: L.Kiss, E.Forro, R.Sillanpaa, F.Fulop|2008|Tetrahedron:Asymm.|19|2856|doi:10.1016/j.tetasy.2008.11.035

Space GroupCrystallographyDiethyl 1-((1R2R3R4R)-3-(t-butoxycarbonylamino)-4-(ethoxycarbonyl)-2-hydroxycyclopentyl)-1H-123-triazole-45-dicarboxylate monohydrateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Impact du système endocannabinoïdien sur la physiologie de l'obésité : effets de l'antagonisme des récepteurs CB1 sur le métabolisme glucido-lipidiqu…

2010

The endocannabinoïd system (ECS) is involved in many biological functions such as regulation of energy metabolism. Recently, several studies have shown an association between obesity and ECS overactivity. In addition, specific CB1R antagonists such as Rimonabant (SR141716) improved metabolic parameters in obese patients essentially through inactivation of central CB1R. However, peripheral CB1R inactivation could also contribute to the improvement of these parameters and it is this notion that we have studied. To this purpose, we tested the effects of SR141716 on obese mice in order to establish relationships between the ECS activity and lipid metabolism by looking more specifically to its r…

[SDV.SA]Life Sciences [q-bio]/Agricultural sciences[SDV.SA] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyStéatoseTissu adipeuxAnandamideMétabolisme glucido-lipidiqueEndocannabinoïde[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyCb1rNo english keywordsCb2rSystème endocannabinoïdienAdiponectineSr141716Foie[ SDV.SA ] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

CCDC 139658: Experimental Crystal Structure Determination

2001

Related Article: P.Lahuerta, E.Moreno, A.Monge, G.Muller, J.Perez-Prieto, M.Sanau, S.-E.Stiriba|2000|Eur.J.Inorg.Chem.||2481|doi:10.1002/1099-0682(200012)2000:12<2481::AID-EJIC2481>3.0.CO;2-M

bis((mu~2~-Trifluoroacetato-OO')-(trifluoroacetato-O)-(((1R2R5S)-2-hydroxy-5-(isopropenyl)-2-methylcyclohexyl)diphenylphosphine-PO)-rhodium(ii)) dihydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Chiroptical Phenomena in Reverse Micelles: The Case of (1R,2S)- Dodecyl (2-hydroxy-1-methyl-2-phenylethyl)dimethylammonium Bromide (DMEB)

2014

(1R,2S)-Dodecyl(2-hydroxy-1-methyl-2-phenylethyl)dimethylammonium bromide (DMEB) aggregates dispersed in carbon tetrachloride have been investigated by Fourier transform infrared (FT-IR), vibrational circular dichroism (VCD) and 1H nuclear magnetic resonance (NMR) spectroscopy at various surfactant concentration and water-to-surfactant molar ratio. Experimental data indicate that, even at the lowest investigated concentration and in absence of added water, DMEBmolecules associate in supramolecular assemblies. At higherDMEBconcentration the aggregates can confine watermolecules,making it plausible to think thatDMEB form reverse micelles and that watermolecules are quite uniformly distributed…

confinement effects2S)-dodecyl(2-hydroxy-1-methyl-2-phenylethyl)dimethylammonium bromide (DMEB)reverse micellegenetic structures(1RPGSE-NMR(1R; 2S)-dodecyl(2-hydroxy-1-methyl-2-phenylethyl)dimethylammonium bromide (DMEB) reverse micelles confinement effects hydrogen bonding vibrational circular dichroism (VCD) PGSE-NMR(1R2S)-dodecyl(2-hydroxy-1-methyl-2-phenylethyl)dimethylammonium bromide (DMEB)confinement effectreverse micellesvibrational circular dichroism (VCD)hydrogen bondingSettore CHIM/02 - Chimica Fisica
researchProduct

Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-233 expressions: A study on postmenopausal mon…

2014

MiRNAs are fine-tuning modifiers of skeletal muscle regulation, but knowledge of their hormonal control is lacking. We used a co-twin case–control study design, that is, monozygotic postmenopausal twin pairs discordant for estrogen-based hormone replacement therapy (HRT) to explore estrogen-dependent skeletal muscle regulation via miRNAs. MiRNA profiles were determined from vastus lateralis muscle of nine healthy 54–62- years-old monozygotic female twin pairs discordant for HRT (median 7 years). MCF-7 cells, human myoblast cultures and mouse muscle experiments were used to confirm estrogen’s causal role on the expression of specific miRNAs, their target mRNAs and proteins and finally the ac…

fosforylaatiovaihdevuodetAKTmiR-182agingmiR-142-3pmTORFOXO3AmiR-233IGF-1 signalingIGF-1R
researchProduct

Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Marke…

2023

Previous evidence suggests that prenatal exposure to THC (pTHC) derails the neurodevelopmental trajectories towards a vulnerable phenotype for impaired emotional regulation and limbic memory. Here we aimed to investigate pTHC effect on hippocampus-related cognitive functions and markers of neuroplasticity in adolescent male offspring. Wistar rats were exposed to THC (2 mg/kg) from gestational day 5 to 20 and tested for spatial memory, object recognition memory and reversal learning in the reinforce-motivated Can test and in the aversion-driven Barnes maze test; locomotor activity and exploration, anxiety-like behaviour, and response to natural reward were assessed in the open field, elevate…

hippocampal excitatory plasticitySettore BIO/14 - FarmacologiaCB1R expressionPharmaceutical Scienceadolescent rat offspringspatial learning and memoryprenatal THC exposure
researchProduct

COVID-19 and diabetes management: What should be considered?

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Clinical effectivenessbusiness.industryEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cardiovascular disease COVID-19 Diabetes DPP4 GLP-1RA Hydroxychloroquine Pioglitazone SGLT-2General Medicinemedicine.diseaseEndocrinologyDiabetes managementDiabetes mellitusInternal MedicinemedicineSodium-Glucose Cotransporter 2 InhibitorIntensive care medicinebusinessPioglitazonemedicine.drugDiabetes research and clinical practice
researchProduct

Future perspectives of the pharmacological management of diabetic dyslipidemia

2019

Introduction: Diabetic dyslipidemia is frequent among patients with type 2 diabetes mellitus (T2DM) and is characterized by an increase in triglycerides (TGs), low-density lipoprotein cholesterol (LDL-C), and small-dense (atherogenic) particles, and by a decrease in low high-density lipoprotein cholesterol (HDL-C) and apolipoprotein (Apo) A1 that are strongly related to insulin resistance. The increased flux of free fatty acids from adipose tissue to the liver aggravates hepatic insulin resistance and promotes all of aspects of the dyslipidemic state. Areas covered: Statins are the first-line agents for treatment while other lipid-lowering drugs (ezetimibe, fibrate and proprotein convertase…

medicine.medical_specialtyApolipoprotein Bmedicine.drug_classglucagon like peptide-1 receptor agonist (GLP-1RA)Fibrate030226 pharmacology & pharmacystatins03 medical and health sciences0302 clinical medicineInsulin resistanceEzetimibeInternal medicinemedicineHumansHypoglycemic AgentsPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsOmega 3 fatty acidDyslipidemiasHypolipidemic Agentsfibratebiologybusiness.industrydyslipidemianutritional and metabolic diseasesType 2 Diabetes MellitusGeneral MedicineLipidmedicine.diseasesodium/glucose cotransporter 2 inhibitors (SGLT-2is)LipidsEndocrinologyDiabetes Mellitus Type 2Cardiovascular Diseases030220 oncology & carcinogenesisDipeptidyl peptidase-4 inhibitors (DPP-4is)Dietary Supplementsbiology.proteinKexinlipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorHydroxymethylglutaryl-CoA Reductase InhibitorsInsulin ResistancebusinessDyslipidemiamedicine.drugezetimibeproprotein convertase subtilisin/kexin type 9 (PCSK9)
researchProduct

Maximum Dynamic Lower-Limb Strength Was Maintained During 24-Week Reduced Training Frequency in Previously Sedentary Older Women.

2018

Walker, S, Serrano, J, and Van Roie, E. Maximum dynamic lower-limb strength was maintained during 24-week reduced training frequency in previously sedentary older women. J Strength Cond Res 32(4): 1063-1071, 2018-There is little study into the effects of reducing strength training below the recommended twice weekly frequency, particularly in older women, despite the possibility that individuals will encounter periods of reduced training frequency. The purpose of the present study was to determine the effects of a period of reduced training frequency on maximum strength and muscle mass of the lower limbs in comparison with the recommended training frequency of twice per week. After an initia…

medicine.medical_specialtyquadricepsTime FactorsStrength trainingPopulationeducationPhysical Therapy Sports Therapy and RehabilitationElectromyographyMuscle massLower limb03 medical and health sciences0302 clinical medicineEMGmedicineHumansOrthopedics and Sports MedicineMuscle StrengthMuscle activityeducationLeg pressMuscle Skeletalta315Agededucation.field_of_studymedicine.diagnostic_testbusiness.industryElectromyographyagingTraining (meteorology)1RMResistance Trainingmaximum force030229 sport sciencesGeneral MedicineMiddle AgedLower Extremitycross-sectional areaPhysical therapyFemalevoimaharjoitteluSedentary Behaviorbusiness030217 neurology & neurosurgeryikääntyneetlihasvoima
researchProduct